IE 11 is not supported. For an optimal experience visit our site on another browser.

Confusion after FDA rejects Pfizer booster shot


There is more confusion following an FDA Advisory Committee’s rejection of the Pfizer booster shot for most adults. However, the extra dose was endorsed for those over 65 and at high risk.